Please join us on October 18-19 at the Hilton Toronto for the 27th Annual Urology Update.
Expert faculty will highlight a program focused on important clinical problems. Take advantage of this opportunity to interact with your colleagues, visitors, and thought leaders from all over North America as you learn about the latest evidence-based approaches. We look forwarding to continuing our tradition of building upon past experiences each year to produce a unique program and we hope to see you there.
Event details and registration info: https://www.cpd.utoronto.ca/urology/
- Prostate cancer
- Bladder cancer
- Kidney cancer
- Pediatric urology
- Neurogenic lower urinary tract dysfunction
- Endourology, MIS, and stones
- Surgical safety in the operating room
- Hyperbaric medicine in urology
- Hyperbaric medicine
Inaugural Astellas Innovation Grants in Prostate Cancer Research have been awarded to:
Dr. Tony Finelli
“Measuring the quality of care, long-term outcomes, and health care utilization in low risk prostate cancer (PC) patients undergoing active surveillance: a population-based approach”.
Dr. Shabir Alibhai
“Prescribing a reduction of sedentary time to improve cancer-related fatigue in men with prostate cancer”.
Dr. Andrei Drabovich
“Non-invasive diagnosis of prostate cancer and stratification of its molecular subtypes using genomic profiling of circulating tumor cells isolated from semen”.
Dr. Neil Fleshner
“Prostate biopsy avoidance using combination PCA3 and multiparametric magnetic resonance scanning in selected patient cohorts”.
CUA Urology WebEx Series
The focus of this accredited WebEx series is on the care of prostate cancer patients, with discussion on the role of the urologist as well as other healthcare professionals. The webcasts would emphasize practical approaches, using the data from recent clinical trials only as a review and support tool, rather than a core part of the presentation. Each topic will be presented twice on each date in order to accommodate live viewing audiences across Canada’s time zones.
For more information and to RSVP, see the Canadian Urological Association event page.
The University of Toronto (UofT) and Astellas Pharma Canada Inc. (Astellas) have jointly established the Astellas Prostate Cancer Innovation Fund at the University of Toronto, with the purpose of supporting and advancing prostate cancer research. Under the direction and supervision of an interdisciplinary UofT review committee, overseen by the Chair of the Division of Urology, the Fund will provide 3 grants in the amount of $50,000. Grants are open to faculty members in the Faculty of Medicine and across UofT’s affiliated hospitals and research institutes, with academic appointment to the following Departments:
- Laboratory Medicine & Pathobiology
- Radiation Oncology
- Medical Imaging
View attachments for complete details and to apply:
Astellas Call for Applications
UofT Astellas Innovation Fund Terms of Reference